Related references
Note: Only part of the references are listed.Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity
Cristina Meregalli et al.
ARCHIVES OF TOXICOLOGY (2020)
Cancer Exacerbates Chemotherapy-Induced Sensory Neuropathy
Stephen N. Housley et al.
CANCER RESEARCH (2020)
A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy
Parul Verma et al.
SCIENTIFIC REPORTS (2020)
Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx)
Hui Lin Cheng et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2019)
Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data
Ellen M. Lavoie Smith et al.
CANCER NURSING (2019)
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
Alex Molassiotis et al.
BMC CANCER (2019)
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Renata Zajaczkowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Management of Immunotherapy-Related Toxicities. Version 1.2019
John A. Thompson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies Systematic review
Annette Johansen et al.
NEUROLOGY (2019)
Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy
Fiona Yeo et al.
SUPPORTIVE CARE IN CANCER (2019)
Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade
Aaron C. Tan et al.
SUPPORTIVE CARE IN CANCER (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing
W. Iris Zhi et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Management of immune related adverse events induced by immune checkpoint inhibition
Andreas Teufel et al.
CANCER LETTERS (2019)
Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment
Nathan P. Staff et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2019)
Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?
Douglas B. Johnson et al.
CLINICAL CANCER RESEARCH (2019)
Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity
Chien-Chun Steven Pai et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data
Ellen M. Lavoie Smith et al.
SUPPORTIVE CARE IN CANCER (2019)
The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
Endale Gebreegziabher Gebremedhn et al.
BMC CANCER (2018)
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy
Cristina Meregalli et al.
EXPERIMENTAL NEUROLOGY (2018)
Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials
Wenxin Luo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
Katherine Stockstill et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity
Akiko Chukyo et al.
NEUROPEPTIDES (2018)
Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity
Amina M. Illias et al.
PAIN (2018)
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve
Paola Alberti et al.
SUPPORTIVE CARE IN CANCER (2018)
In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials
Ellen M. Lavoie Smith et al.
CANCER CONTROL (2018)
Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain
Malik Bechakra et al.
MOLECULAR PAIN (2018)
Gaining on Pain
Edward C. Emery et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
Fei-ze Wu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
Neriman Yukselturk Simsek et al.
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING (2018)
Chemotherapy-induced neuropathiesa growing problem for patients and health care providers
Marta Banach et al.
BRAIN AND BEHAVIOR (2017)
The psychometric properties of the Turkish version of the Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT)
Seving Kutluturkan et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2017)
Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons
Markus Leo et al.
EXPERIMENTAL NEUROLOGY (2017)
Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study
Roser Velasco et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2017)
Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics
Andreas A. Argyriou et al.
NATURE REVIEWS NEUROLOGY (2017)
Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis
Tomohiro F. Nishijima et al.
ONCOLOGIST (2017)
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
Jacobien M. Kieffer et al.
QUALITY OF LIFE RESEARCH (2017)
Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy
Robert Knoerl et al.
SUPPORTIVE CARE IN CANCER (2017)
Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials
Jennifer Le-Rademacher et al.
SUPPORTIVE CARE IN CANCER (2017)
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Hana Starobova et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy
Preet G. S. Makker et al.
PLOS ONE (2017)
Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy
Leonidas Apostolidis et al.
PLOS ONE (2017)
Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review
Jeremy N. Pulvers et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
Neurological toxicities associated with immune-checkpoint inhibitors
Mehdi Touat et al.
CURRENT OPINION IN NEUROLOGY (2017)
Evaluation of Bortezomib-Induced Neuropathy Using Total Neuropathy Score (Reduced and Clinical Versions) and NCI CTCAE v4.0 in Newly Diagnosed Patients With Multiple Myeloma Receiving Bortezomib-Based Induction
Arjun Lakshman et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)
Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review
S. J. L. Flatters et al.
BRITISH JOURNAL OF ANAESTHESIA (2017)
Update on Chemotherapy-Induced Peripheral Neuropathy
Comana Cioroiu et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Reliability testing of oxaliplatin-associated neurotoxicity questionnaire (OANQ), a pilot study
E. Gustafsson et al.
SUPPORTIVE CARE IN CANCER (2016)
Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice
A. J. M. Beijers et al.
SUPPORTIVE CARE IN CANCER (2016)
Management of toxicities of immune checkpoint inhibitors
Lavinia Spain et al.
CANCER TREATMENT REVIEWS (2016)
Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population
Floortje Mols et al.
EUROPEAN JOURNAL OF CANCER (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy
Mehdi Saad et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy
Hongmei Zhang et al.
JOURNAL OF PAIN (2016)
OXIDATIVE STRESS IN THE DEVELOPMENT, MAINTENANCE AND RESOLUTION OF PACLITAXEL-INDUCED PAINFUL NEUROPATHY
Natalie A. Duggett et al.
NEUROSCIENCE (2016)
Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain
Marco Sisignano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Up-regulation of CX3CL1 via Nuclear Factor-κB-dependent Histone Acetylation Is Involved in Paclitaxel-induced Peripheral Neuropathy
Dai Li et al.
ANESTHESIOLOGY (2015)
Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: a case-controlled feasibility study
Scott C. Adams et al.
BMC CANCER (2015)
Taxane induced neuropathy in patients affected by breast cancer: Literature review
Francesca De Iullis et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Chemotherapy-induced peripheral neurotoxicity
Guido Cavaletti et al.
CURRENT OPINION IN NEUROLOGY (2015)
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
L. Eckhoff et al.
EUROPEAN JOURNAL OF CANCER (2015)
Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy
Rita Kramer et al.
FASEB JOURNAL (2015)
Validity of the Chemotherapy-induced Peripheral Neuropathy Self-Check Sheet
Yumiko Miyoshi et al.
INTERNAL MEDICINE (2015)
Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
Barthelemy Diouf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy
Lisa A. Griffiths et al.
JOURNAL OF PAIN (2015)
Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale
Tito R. Mendoza et al.
JOURNAL OF PAIN (2015)
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc(C)) in patients with chemotherapy-induced peripheral neuropathy
Davide Binda et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2015)
Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia
Ellen M. Lavoie Smith et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2015)
Corneal sub-basal neural damage pattern in multiple myeloma patients treated with bortezomib: an in vivo confocal study
Federica Cocito et al.
LEUKEMIA & LYMPHOMA (2015)
Mechanisms of distal axonal degeneration in peripheral neuropathies
Christopher R. Cashman et al.
NEUROSCIENCE LETTERS (2015)
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
V. A. Carozzi et al.
NEUROSCIENCE LETTERS (2015)
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou C. Dueck et al.
JAMA ONCOLOGY (2015)
Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy
Maryam Ferdousi et al.
PLOS ONE (2015)
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Annalisa Canta et al.
TOXICS (2015)
Enhanced Excitability of Primary Sensory Neurons and Altered Gene Expression of Neuronal Ion Channels in Dorsal Root Ganglion in Paclitaxel-induced Peripheral Neuropathy
Haijun Zhang et al.
ANESTHESIOLOGY (2014)
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P. Alberti et al.
ANNALS OF ONCOLOGY (2014)
Bortezomib-induced peripheral neurotoxicity: an update
Andreas A. Argyriou et al.
ARCHIVES OF TOXICOLOGY (2014)
Bortezomib-induced neuropathy: Axonal membrane depolarization precedes development of neuropathy
Saiko Nasu et al.
CLINICAL NEUROPHYSIOLOGY (2014)
Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies
T. Kroigard et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1
Kali Janes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
Roser Velasco et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study
Kathleen A. Griffith et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2014)
Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study
Chiara Briani et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2014)
Neurotoxicity induced by antineoplastic proteasome inhibitors
Albert Ale et al.
NEUROTOXICOLOGY (2014)
Does the epidermal nerve fibre density measured by skin biopsy in patients with peripheral neuropathies correlate with neuropathic pain?
A. Truini et al.
PAIN (2014)
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
Marta Seretny et al.
PAIN (2014)
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways
Kali Janes et al.
PAIN (2014)
Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
Aparna Areti et al.
REDOX BIOLOGY (2014)
Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy
Antoinetta Beijers et al.
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY (2014)
Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin
Linh M. Alejandro et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Persistent Hyperalgesia in the Cisplatin-Treated Mouse as Defined by Threshold Measures, the Conditioned Place Preference Paradigm, and Changes in Dorsal Root Ganglia Activated Transcription Factor 3: The Effects of Gabapentin, Ketorolac, and Etanercept
Hue Jung Park et al.
ANESTHESIA AND ANALGESIA (2013)
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G. Cavaletti et al.
ANNALS OF ONCOLOGY (2013)
Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia
Marta Pevida et al.
BRAIN RESEARCH BULLETIN (2013)
Clinical pattern and associations of oxaliplatin acute neurotoxicity
Andreas A. Argyriou et al.
CANCER (2013)
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
D. Binda et al.
EUROPEAN JOURNAL OF CANCER (2013)
Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings
C. Briani et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Corneal innervation as a window to peripheral neuropathies
Giulio Ferrari et al.
EXPERIMENTAL EYE RESEARCH (2013)
Electrophysiological Features of Taxane-Induced Polyneuropathy in Patients With Breast Cancer
Xi Chen et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2013)
Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy
Marta Campagnolo et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2013)
An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways
Jennifer R. Deuis et al.
PAIN (2013)
Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus
Hsin-Ying Wang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
Ellen M. Lavoie Smith et al.
QUALITY OF LIFE RESEARCH (2013)
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy
Xiao-Min Wang et al.
CYTOKINE (2012)
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin
J. C. McHugh et al.
EUROPEAN JOURNAL OF CANCER CARE (2012)
Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer
Naohiko Inoue et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
Tadashi Yokosuka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer
John Dulos et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Targeting the Overproduction of Peroxynitrite for the Prevention and Reversal of Paclitaxel-Induced Neuropathic Pain
Timothy Doyle et al.
JOURNAL OF NEUROSCIENCE (2012)
Evidence That Spinal Astrocytes but Not Microglia Contribute to the Pathogenesis of Paclitaxel-Induced Painful Neuropathy
Haijun Zhang et al.
JOURNAL OF PAIN (2012)
Vincristine exacerbates asymptomatic Charcot-Marie-Tooth disease with a novel EGR2 mutation
Tomonori Nakamura et al.
NEUROGENETICS (2012)
Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients The introduction of a new measure
C. M. L. Driessen et al.
SUPPORTIVE CARE IN CANCER (2012)
Development and Psychometric Evaluation of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool
Cindy S. Tofthagen et al.
CANCER NURSING (2011)
Current status on electrodiagnostic standards and guidelines in neuromuscular disorders
Anders Fuglsang-Frederiksen et al.
CLINICAL NEUROPHYSIOLOGY (2011)
Chemotherapy-Induced Neuropathy
Guido Cavaletti et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2011)
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy
Huaien Zheng et al.
EXPERIMENTAL NEUROLOGY (2011)
Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)
Ariel C. Bulua et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
Guido Cavaletti et al.
LANCET ONCOLOGY (2011)
EARLY, PROGRESSIVE, AND SUSTAINED DYSFUNCTION OF SENSORY AXONS UNDERLIES PACLITAXEL-INDUCED NEUROPATHY
Susanna B. Park et al.
MUSCLE & NERVE (2011)
Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility
Susanna B. Park et al.
ONCOLOGIST (2011)
Chemotherapy-induced neuropathic pain
Paul Farquhar-Smith
Current Opinion in Supportive and Palliative Care (2011)
The Validity of Neuropathy and Neuropathic Pain Measures in Patients With Cancer Receiving Taxanes and Platinums
Ellen M. Lavoie Smith et al.
ONCOLOGY NURSING FORUM (2011)
Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability
Andrew Hill et al.
BMC CANCER (2010)
The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
Ellen M. Lavoie Smith et al.
CANCER NURSING (2010)
Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
Guido Cavaletti et al.
EUROPEAN JOURNAL OF CANCER (2010)
Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents
Amol M. Patwardhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients
Roser Velasco et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study
Giuseppe Lauria et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin
Pei Pei Gan et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice
Lauren E. Ta et al.
MOLECULAR PAIN (2010)
Persistent Mobility Disability After Neurotoxic Chemotherapy
Elizabeth S. Hile et al.
PHYSICAL THERAPY (2010)
Persistent neuropathy after treatment with cisplatin and oxaliplatin
Elke E. M. Brouwers et al.
ACTA ONCOLOGICA (2009)
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
Susanna B. Park et al.
BRAIN (2009)
Therapy of chemotherapy-induced peripheral neuropathy
Thomas J. Kaley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Acute Abnormalities of Sensory Nerve Function Associated With Oxaliplatin-Induced Neurotoxicity
Susanna B. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
PERIPHERAL NERVE SIZE IN NORMALS AND PATIENTS WITH POLYNEUROPATHY: AN ULTRASOUND STUDY
Craig M. Zaidman et al.
MUSCLE & NERVE (2009)
Role of MAPKs in platinum-induced neuronal apoptosis
Arianna Scuteri et al.
NEUROTOXICOLOGY (2009)
Oxaliplatin-induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia
Mariko Sakurai et al.
PAIN (2009)
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study
N. Attal et al.
PAIN (2009)
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
Kojiro Shimozuma et al.
SUPPORTIVE CARE IN CANCER (2009)
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity
Noelle Callizot et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Immune-mediated neuropathies in myeloma patients treated with bortezomib
Sabrina Ravaglia et al.
CLINICAL NEUROPHYSIOLOGY (2008)
Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients
Kayihan Uluc et al.
CLINICAL NEUROPHYSIOLOGY (2008)
Peripheral nerve damage associated with administration of taxanes in patients with cancer
Andreas A. Argyriou et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
Dennis Revicki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Systems biology - Metabonomics
Jeremy K. Nicholson et al.
NATURE (2008)
Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings
Caraceni Augusto et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
The paclitaxel acute pain syndrome: Sensitization of nociceptors as the putative mechanism
Charles L. Loprinzi et al.
CANCER JOURNAL (2007)
Chemosensory changes experienced by patients undergoing cancer chemotherapy: A qualitative interview study
Britt-Marie Bernhardson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
Guido Cavaletti et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2007)
Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy
Meredith A. Wampler et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2007)
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats
Annemarie Ledeboer et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy
A. A. Argyriou et al.
EUROPEAN JOURNAL OF CANCER CARE (2007)
Quantitative sensory findings in patients with bortezomib-induced pain
Juan P. Cata et al.
JOURNAL OF PAIN (2007)
Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study
H. Q. Huang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain
Patrick M. Dougherty et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
Andreas A. Argyriou et al.
ACTA ONCOLOGICA (2007)
Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies
A. Krarup-Hansen et al.
BRAIN (2007)
Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats
Anke Tomaszewski et al.
NEUROTOXICOLOGY (2007)
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction
SJL Flatters et al.
PAIN (2006)
Scale for chemotherapy-induced long-term neurotoxicity (SCIN):: Psychometrics, validation, and findings in a large sample of testicular cancer survivors
Jan Oldenburg et al.
QUALITY OF LIFE RESEARCH (2006)
Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy
FH Hausheer et al.
SEMINARS IN ONCOLOGY (2006)
The impact of paclitaxel or cisplatin-based chemotherapy on sympathetic skin response: a prospective study
AA Argyriou et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer
GD Leonard et al.
BMC CANCER (2005)
Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?
AA Argyriou et al.
SUPPORTIVE CARE IN CANCER (2005)
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
TJ Postma et al.
EUROPEAN JOURNAL OF CANCER (2005)
A pilot study on the effect of acetyl-L-carnitine in paclitaxel-and cisplatin-induced peripheral neuropathy
A Maestri et al.
TUMORI JOURNAL (2005)
Chemotherapy-induced peripheral neuropathy
T Armstrong et al.
ONCOLOGY NURSING FORUM (2005)
[Ca2+]i signaling between mitochondria and endoplasmic reticulum in neurons is regulated by microtubules -: From mitochondrial permeability transition pore to Ca2+-induced Ca2+ release
SL Mironov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Metals, toxicity and oxidative stress
M Valko et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients
PM Dougherty et al.
PAIN (2004)
Oxidation of methionine residues of proteins: Biological consequences
ER Stadtman et al.
ANTIOXIDANTS & REDOX SIGNALING (2003)
DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells
S Faivre et al.
BIOCHEMICAL PHARMACOLOGY (2003)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore
JF Kidd et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity
MJ van den Bent et al.
EUROPEAN JOURNAL OF CANCER (2002)
Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling
ES McDonald et al.
NEUROBIOLOGY OF DISEASE (2002)
Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis
M von Schlippe et al.
BRITISH JOURNAL OF CANCER (2001)
Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol™) in murine and human breast cancer cell lines
M Zaks-Zilberman et al.
CYTOKINE (2001)
Epidermal nerve fiber density in sensory ganglionopathies: Clinical and neurophysiologic correlations
G Lauria et al.
MUSCLE & NERVE (2001)
Share Paper
